Bioprocessing - Upstream & Downstream

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

As biologics become more complex, mass spec becomes more indispensable than ever in the drug developer’s toolbox.

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

Biopharma has been using lyophilization to stabilize injectables for more than 80 years, but the technique is capable of so much more.

Now that the 2025 Power List is live, we speak with the people working hard every day to make a difference.

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB.

Our latest roundup reports on Trump's “most favored nation” order, an EMA investigation into finasteride, and Novo Nordisk’s continued R&D for obesity

When it comes to continuous cGMP biomanufacturing, Just – Evotec Biologics’ J.DESIGN platform integrates data analytics and continuous manufacturing

Trump continues to send shockwaves through the industry. We look at FDA disruption, tariffs, funding volatility, and more.